Following the launch of Locox TT, TVM has introduced Locox TT Mini which is specifically aimed at cats and small dogs. The product contains a unique and comprehensive blend of active ingredients to help support joint health.
Locox TT was developed to include high levels of EPA and DHA Omega-3, sourced from sustainable fishing. Independent laboratory analysis has also shown that Locox TT contains over four times more Omega-3s than the market leading supplement.
The new Locox TT Mini is packed full of the same high-quality ingredients with a specifically formulated tab shape and size favoured for cats. In addition, the chicken flavoured tabs have been independently shown to have a higher palatability score than competitor cat joint supplements, with only one tab required daily and no loading phase necessary.
It is the third product to be manufactured using TVM’s patented Tasty Tech technology, which guarantees the preservation of delicate ingredients and ensures high palatability.
Along with its robust Omega-3 profile, Locox TT Mini also combines high quality glucosamine and chondroitin, and powerful antioxidants.
Will Peel, TVM’s product manager says: “Following the launch of the initial Locox TT product, we have developed Locox TT Mini specifically for cats and small dogs. Many cats suffer with joint stiffness which can often be harder to recognise than with dogs, therefore there is a need for a highly palatable joint supplement specific to a cat’s requirements.”
To find out more, please visit the TVM website or contact your local TVM territory manager.